SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor ...
Two new Canadian studies are the largest to date looking at death rates and psychosis associated with cannabis use disorder.
Study results show that genetic sensitivity to stress was linked to a 49% higher risk of lung cancer in people of European ...
That is about to change, with $6 million awarded to National Cancer Centre Singapore (NCCS) senior consultant surgeon Pierce ...
Australia has long been a trailblazer in cancer control, with over 100,000 lives saved in the last 25 years thanks to ...
U.S. Secretary of Health nominee Robert F. Kennedy Jr. has been filmed seemingly putting a blue liquid into a glass of water ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc. announced ...
Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug ...
February is American Heart Month, a highlight of which is Wear Red Day, which aims to raise awareness about heart disease in ...
Health-related technologies have evolved significantly in the modern world, offering people innovative tools to manage their ...
“Broken skin barriers” are real. They’re the subject of great interest from " skinfluencers " on TikTok, but they’re also ...
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its ...